Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes

Cardiovascular Journal of South Africa

Volumn 17, Issue 2, 2006, Pages 60-66

  Ranjith, N ^a   Pegoraro, R J ^b   Naidoo, D P ^c   Esterhuizen, T M ^d  

^a RK Khan Hospital   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c INKOSI ALBERT LUTHULI CENTRAL HOSPITAL   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY CARE; DISEASE PREDISPOSITION; FAMILY HISTORY; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; OBESITY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOUTH AFRICA;

BIOLOGICAL MARKERS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33745649876     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. McDonagh TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 2004; 6: 269-273.
2. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
3. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6: 257-260.
4. De Lemos JA, Marrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
5. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002; 40: 437-445.
6. Seedat YK. Ethnicity, hypertension, coronary heart disease, and renal disease in South Africa. Ethnicity Hlth 1996; 1: 349-357.
7. Ranjith N, Pegoraro RJ, Naidoo DP. Demographic data and outcome of acute coronary syndrome in the South African Asian Indian population. Cardiovasc J South Afr 2005; 16: 48-54.
8. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
9. Zimmerman FH, Cameron A, Fisher LD, et al. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995; 26: 61-65.
10. Folland ED, Parisis AF, Moyniham PF, et al. Assessment of left ventricular ejection fraction and volumes by real time, two dimensional echocardiography: a comparison of cineangiographic and radio nuclide techniques. Circulation 1972; 60: 760-766.
11. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
12. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
13. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
14. Maffei S, Del Ry S, Prontera C, et al. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in post-menopausal women. Clin Sci 2001; 101: 447-453.
15. Clark BA, Elahi D, Shannon RP, et al. Influence of age and dose on the end-organ responses to atrial natriuretic peptide in humans. Am J Hypertens 1991; 4: 500-507.
16. Baxter GF. Natriuretic peptides and myocardial ischaemia. Basic Res Cardiol 2004; 99: 90-93.
17. Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction. Eur Heart J 2000; 21: 1514-1521.
18. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischaemia. FASEB J 2003; 17: 1105-1107.
19. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-322.
20. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation myocardial infarction. J Am Coll Cardiol 2003; 41: 1264-1272.
21. Heeschen C, Hamm CW, Mitrovicn V, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-3212.
22. Bassan R, Potsch A, Maisel A, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005; 26: 234-240.
23. Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005; 26: 241-249.